Lv4
595 积分 2020-04-26 加入
Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia—results of the AMLSG 11-08 trial
4小时前
待确认
Dasatinib maintenance following allogeneic transplantation in acute myeloid leukemia with KIT mutation
4小时前
已完结
KIT pathway upregulation predicts dasatinib efficacy in acute myeloid leukemia
4小时前
待确认
Evaluation of lymphocytes subpopulations and natural killer cells in peripheral blood of patients treated for dermatophyte onychomycosis
23天前
已完结
Targeting the tumor microenvironment in primary central nervous system lymphoma: Implications for prognosis
3个月前
已完结
Salvage therapy with “Dara‐KDT‐P(A)CE” in heavily pretreated, high‐risk, proliferative, relapsed/refractory multiple myeloma
3个月前
已完结
VDTPACE As Salvage Therapy For Heavily Pretreated MM Patients
3个月前
已完结
Autologous stem cell transplantation for relapsed and primary refractory myeloma
3个月前
已完结
T cells in the skin: lymphoma and inflammatory skin disease
3个月前
已完结
Aclarubicin in the treatment of de-novo acute myelocytic leukaemia
3个月前
已关闭
皖公网安备34019202002308
